Rx-to-OTC switch meeting
This article was originally published in The Tan Sheet
Executive Summary
"Insuring the Profitability of Rx-to-OTC Switches" sponsored by the Institute for International Research is to be held Oct. 22-23 at the Radisson Empire Hotel in New York City. Speakers will include Bayer Consumer Care Director of Medical Affairs & Clinical Research Randy Koslo, Schachtel Associates President Bernard Schachtel, MD, and Whitehall-Robins Worldwide Regulatory Affairs VP Sharon Heddish...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC